Insulet Outlines Long-Term Strategy to Drive Growth and Value Creation at 2025 Investor Day

Insulet Corporation (NASDAQ: PODD) ("Insulet" or the "Company"), the global leader in tubeless insulin pump technology with ...

Transwestern Awarded Asset Management of Historic PacMutual Complex

Transwestern Real Estate Services has been selected to provide asset services for the historic, three-building, ...

Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil® as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that given the high rate of non-responsiveness to therapies in ...

Harrow Announces Third Quarter 2025 Financial Results

Total revenues of $71.6 million, a 45% increase over $49.3 million recorded in the prior-year periodGAAP net income of $1.0 millionAdjusted EBITDA of $22.7 millionCash and cash equivalents of $74.3 ...